Bank of Montreal’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
NIM
FHA
AAM
WAM
1WA
Bank of Montreal's HQL Position: Q2 2022 in Review
Bank of Montreal sold out of abrdn Life Sciences Investors (HQL) in Q2 2022, closing a stake of 16,163 shares — an estimated $284K sold.
Bank of Montreal first reported a position in HQL in Q2 2015 and held it in 12 quarters. The position peaked at $792K in Q3 2020. 65 funds tracked by Wall St. Rank hold HQL as of Q2 2022.
- Bank of Montreal reported no remaining abrdn Life Sciences Investors position as of Q2 2022 after selling out during the quarter.
- Bank of Montreal sold 16,163 abrdn Life Sciences Investors shares in Q2 2022, an estimated $284K.
- Bank of Montreal first reported a position in abrdn Life Sciences Investors in Q2 2015 and held it in 12 quarters.
- Bank of Montreal's abrdn Life Sciences Investors position peaked at $792K in Q3 2020.
- 65 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2022.
Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.